Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer

This publication has 25 references indexed in Scilit:

• Chemotherapy for pancreatic carcinoma
  Cancer, 1996
• A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
  Annals of Oncology, 1996
• Phase II study of gemcitabine in patients with advanced pancreatic cancer
  British Journal of Cancer, 1996
• Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas
  Investigational New Drugs, 1994
• A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma
  Cancer, 1991
• A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin
  Cancer, 1990
• Continuous 5-Fluorouracil (5FU) Infusion in Carcinoma of the Pancreas: A Phase II Study
  The Lancet Healthy Longevity, 1988
• Chemotherapy for advanced pancreatic cancer.A comparison of 5-fluorouracil, adriamycin, and mitomycin (fam) with 5-fluorouracil, streptozotocin, and mitomycin (fsm)
  Cancer, 1986
• A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric Carcinoma
  JAMA, 1985
• Chemotherapy of Gastrointestinal Cancer
  Clinics in Gastroenterology, 1976